Literature DB >> 10587969

Allogeneic hematopoietic stem-cell engraftment and graft failure.

A Woolfrey1, C Anasetti.   

Abstract

Two immunologically mediated reactions, the graft-versus-host (GvH) and host-versus-graft (HvG) responses, form primary and opposing barriers to successful transplantation of allogeneic hematopoietic stem-cells (HSC). The HvG barrier is set by the strength of the allogeneic immune response, which is determined by antigenic stimulation provided by donor cells, owing to differences in histocompatibility antigens, and the capacity of host immune cells to generate a response. Risk of graft failure must be viewed as the interplay of multiple factors, including degree of human leukocyte antigen and minor histocompatibility antigen disparity, capacity of host immune response, and the capacity of donor hematopoietic and immunologic cells for overcoming residual host immunity.

Entities:  

Mesh:

Year:  1999        PMID: 10587969     DOI: 10.1034/j.1399-3046.1999.00068.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  6 in total

1.  Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.

Authors:  Sebastian P Haen; Michael Schumm; Christoph Faul; Lothar Kanz; Wolfgang A Bethge; Wichard Vogel
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-14       Impact factor: 4.553

2.  Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.

Authors:  Sebastian P Haen; Vicky Eyb; Nora Mirza; Aline Naumann; Andreas Peter; Markus W Löffler; Christoph Faul; Wichard Vogel; Wolfgang A Bethge; Hans-Georg Rammensee; Lothar Kanz; Martin Heni
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-16       Impact factor: 4.553

3.  Zebrafish model for allogeneic hematopoietic cell transplantation not requiring preconditioning.

Authors:  Isabell Hess; Norimasa Iwanami; Michael Schorpp; Thomas Boehm
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

4.  Lack of antidonor alloantibody does not indicate lack of immune sensitization: studies of graft loss in a haploidentical hematopoietic cell transplantation swine model.

Authors:  Raimon Duran-Struuck; Abraham Matar; Rebecca Crepeau; Ashley Gusha; Marian Schenk; Isabel Hanekamp; Vimukthi Pathiraja; Thomas R Spitzer; David H Sachs; Christene A Huang
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-11       Impact factor: 5.742

5.  Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.

Authors:  Cen Tang; Feng Chen; Danqing Kong; Qinfen Ma; Haiping Dai; Jia Yin; Zheng Li; Jia Chen; Xiaming Zhu; Xinliang Mao; Depei Wu; Xiaowen Tang
Journal:  J Hematol Oncol       Date:  2018-08-16       Impact factor: 17.388

6.  Rescue treatment with eltrombopag in refractory cytopenias after allogeneic stem cell transplantation.

Authors:  Semra Aydin; Chiara Dellacasa; Sara Manetta; Luisa Giaccone; Laura Godio; Giorgia Iovino; Benedetto Bruno; Alessandro Busca
Journal:  Ther Adv Hematol       Date:  2020-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.